Inventor · disambiguated record
Detlev Sülzle
Also filed as: SUELZLE DETLEV · SULZLE DETLEV · SÜLZLE DETLEV
26 granted patents·27 pending applications·26 citations·filing 1999–2025
92Inventor score
Top patents by PatentIndex Score
53 records- 0194US11773070B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Oct 3, 2023·2 cites·9 claims
- 0290US12258323B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Mar 25, 2025·1 cites·15 claims
- 0390US11427553B2DihydrooxadiazinonesBAYER AG·Filed 2018·Granted Aug 30, 2022·4 cites·11 claims
- 0480US9382255B2Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitorsBayer Pharma AG·Filed 2013·Granted Jul 5, 2016·3 cites·9 claims
- 0575US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 0674US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 0774US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 0874US2024182452A16-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancerBAYER AG·Filed 2023·Application pending·0 cites
- 0972US9540392B2ThienopyrimidinesBayer Pharma AG·Filed 2013·Granted Jan 10, 2017·2 cites·10 claims
- 1071US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 1170US7164016B2Macrocyclic metal complexes and their use for the production of conjugates with biomoleculesSCHERING AG·Filed 2002·Granted Jan 16, 2007·2 cites·23 claims
- 1266US10487092B2Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·1 cites·22 claims
- 1365US12427153B21,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 1463US7067667B2Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitorsSCHERING AG·Filed 2003·Granted Jun 27, 2006·2 cites·10 claims
- 1562US11311520B2Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2020·Granted Apr 26, 2022·0 cites·7 claims
- 1662US2024150277A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1761US2011165076A1Novel [f-18]- labelled l-glutamic acid and l-glutamine derivatives (i), use thereof and method for their productionBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1860US2025170136A11,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2025·Application pending·0 cites
- 1960US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 2059US2007009442A1Macrocyclic metal complexes and their use for the production of conjugates with biomoleculesPLATZEK JOHANNES·Filed 2006·Application pending·0 cites
- 2159US2007014725A1Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapyPLATZEK JOHANNES·Filed 2006·Application pending·0 cites
- 2256US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 2356US2025042863A1Method for producing isoxazolinecarboxylic acid derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 2454US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 2553US2003206865A1Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapySCHERING AG·Filed 2002·Application pending·0 cites
- 2652US9556181B2Substituted pyrazolopyrimidinylamino-indazolesBayer Pharma AG·Filed 2014·Granted Jan 31, 2017·0 cites·9 claims
- 2752US2016159816A1Substituted thienopyrimidines and pharmaceutical use thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2851US2019350910A1Substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2950US2015252047A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseasesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3050US2007049583A1Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agentsSCHERING AG·Filed 2006·Application pending·0 cites
- 3149US2023365554A1Substituted pyrrolo-pyridinone derivatives and therapeutic uses thereofBROAD INST INC·Filed 2021·Application pending·0 cites
- 3249US2015132229A1Bis azainositol heavy metal complexes for x-ray imagingBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3347US9675612B2Substituted thiazolopyrimidinesBayer Pharma AG·Filed 2014·Granted Jun 13, 2017·0 cites·11 claims
- 3446US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 3545US2016297833A1Thienopyrimidines as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3644US2016159789A1Substituted pyrazolopyridinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3743US9783543B2AminoimidazopyridazinesBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·0 cites·8 claims
- 3843US9745304B2Amidoimidazopyridazines as MKNK-1 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·0 cites·9 claims
- 3943US9296757B2Substituted benzothienopyrimidinesBayer Pharma AG·Filed 2013·Granted Mar 29, 2016·0 cites·9 claims
- 4043US7141566B1Benzoxazine and benzothiazine derivatives and the use thereof in medicamentsSCHERING AG·Filed 2000·Granted Nov 28, 2006·0 cites·16 claims
- 4143US2015133426A1Substituted pyrrolopyrimidinesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 4243US2016060209A1Bis azainositol hafnium complexes for x-ray imagingBAYER PHARMA AG ÜSS·Filed 2014·Application pending·0 cites
- 4342US9777004B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2013·Granted Oct 3, 2017·0 cites·9 claims
- 4442US2015218173A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
- 4541US9643974B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·0 cites·9 claims
- 4640US2018148418A1Amido-substituted cyclohexane derivativesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 4736US2019388425A1Substituted imidazopyridinpyrimidinesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 4835US10214545B2Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disordersBayer Pharma AG·Filed 2015·Granted Feb 26, 2019·0 cites·21 claims
- 4934US6391887B13,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitorsSCHERING AG·Filed 1999·Granted May 21, 2002·2 cites·21 claims
- 5032US2017107229A1Substituted tetrahydropyridothienopyrimidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Detlev Sülzle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →